...
首页> 外文期刊>Journal of general internal medicine >Diabetes control among hispanics in the action to control cardiovascular risk in diabetes trial
【24h】

Diabetes control among hispanics in the action to control cardiovascular risk in diabetes trial

机译:糖尿病患者中的糖尿病控制在控制糖尿病风险中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Hispanics in the United States represent diverse racial, ethnic, and socioeconomic groups, and manifest heterogeneous cardiovascular risks including diabetes. It is not known if there are residual differences in the control of diabetes among Hispanic groups given uniform access to diabetes care. OBJECTIVE: To evaluate glucose control differences among Mexicans, Puerto Ricans, and Dominicans receiving substantial diabetes care and support in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. DESIGN: Secondary analysis of data from a randomized trial comparing two treatment strategies: intensive, targeting glycated hemoglobin below 6.0 %, and standard, targeting glycated hemoglobin between 7.0 % and 7.9 %. PARTICIPANTS: Seven hundred and sixteen Hispanic and 6066 non-Hispanic white participants were recruited from 77 clinical sites across the United States and Canada. There were 243 Mexicans, 199 Puerto Ricans, and 150 Dominicans; and 135 of these Hispanic groups were born in the United States. MAIN MEASURE: Glycated hemoglobin RESULTS: Compared to Puerto Ricans, Mexicans were more likely (HR=1.38, CI:0.90-2.10) and Dominicans as likely (HR=1.01, CI:0.66-1.54) to achieve glycated hemoglobin goal in the intensive arm. Participants born in the United States achieved glycated hemoglobin goal at a higher rate than those born elsewhere (HR=1.57, CI:0.99-2.51 in the intensive arm, HR=1.51, CI:0.95-2.43 in the standard arm). These differences were not statistically significant. In the intensive arm, Puerto Ricans (OR=0.47, CI:0.31-0.71), and Dominicans (OR=0.41, CI:0.26-0.66) were less likely than non-Hispanic whites to achieve glycated hemoglobin goal, whereas the difference between non-Hispanic whites and Mexicans was not statistically significant, (OR=0.66, CI:0.43-1.02). CONCLUSIONS: Hispanic groups, given access to comprehensive diabetes care, differed from each other nonsignificantly and had a variable divergence from non-Hispanic whites in achieving intensive glycated hemoglobin goal. These differences, if confirmed, could be due to such factors as variable acculturation and functional health literacy levels that were not measured in the ACCORD trial, but should be further explored in future studies.
机译:背景:美国的西班牙裔代表着不同的种族,族裔和社会经济群体,并表现出包括糖尿病在内的多种心血管疾病风险。尚不清楚在统一获得糖尿病护理的西班牙裔人群中,糖尿病的控制是否存在残留差异。目的:为了评估在糖尿病控制心血管风险行动(ACCORD)试验中接受大量糖尿病护理和支持的墨西哥人,波多黎各人和多米尼加人之间的血糖控制差异。设计:来自一项随机试验的数据的二次分析,比较了两种治疗策略:强化,靶向糖化血红蛋白低于6.0%和标准靶向糖化血红蛋白在7.0%至7.9%之间。参与者:从美国和加拿大的77个临床地点招募了716名西班牙裔和6066名非西班牙裔白人参与者。有243名墨西哥人,199名波多黎各人和150名多米尼加人;这些西班牙裔群体中有135个在美国出生。主要指标:糖化血红蛋白结果:与波多黎各人相比,墨西哥人更有可能(HR = 1.38,CI:0.90-2.10)和多米尼加人(HR = 1.01,CI:0.66-1.54)在强化饮食中达到糖化血红蛋白的目标。臂。在美国出生的参与者达到糖化血红蛋白的目标的比率要比在其他地方出生的参与者更高(强化组的HR = 1.57,CI:0.99-2.51,标准组的HR = 1.51,CI:0.95-2.43)。这些差异无统计学意义。在强化组中,波多黎各人(OR = 0.47,CI:0.31-0.71)和多米尼加人(OR = 0.41,CI:0.26-0.66)较非西班牙裔白人实现糖化血红蛋白目标的可能性更低,而两者之间的差异非西班牙裔白人和墨西哥人之间无统计学意义(OR = 0.66,CI:0.43-1.02)。结论:西班牙裔人群能够获得全面的糖尿病护理,彼此之间无显着差异,并且在实现强化糖化血红蛋白目标方面与非西班牙裔白人之间存在差异。如果得到证实,这些差异可能是由于适应性和功能健康素养水平可变等因素引起的,这些因素在ACCORD试验中并未测量,但应在以后的研究中进一步探讨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号